Status:
COMPLETED
Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke
Lead Sponsor:
Istanbul Medeniyet University
Conditions:
Hyperhomocysteinemia, Thrombotic, Cbs-Related
Ischemic Stroke
Eligibility:
All Genders
Phase:
NA
Brief Summary
Adult onset epileptic seizures is rare and often associated with metabolic disorders, drugs and intracranial pathologies such as ischemia, hemorrhage or space-occupying lesions. Methylenetetrahydrofol...
Detailed Description
Epileptic seizures that begin in adulthood seriously affect patients, their relatives and the society in which they live financially and psychologically. The etiology of epileptic seizures starting at...
Eligibility Criteria
Inclusion
- The patients with adult-onset epileptic seizures and diagnosed ischemic stroke in 3 years period.
Exclusion
- Pediatric patients with epileptic seizures
Key Trial Info
Start Date :
October 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04287881
Start Date
October 31 2019
End Date
February 20 2020
Last Update
February 27 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Zeynep Orhon
Istanbul, Turkey (Türkiye), 34722
2
Istanbul MU Goztepe Training and Research Hospital
Istanbul, Turkey (Türkiye), 34730